TimesSquare Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

TimesSquare Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-41,700	Closed	-$1.03M	–	200
2022 Q2	$1.03M	Buy	41,700 +13,200	+46%	+$291K	0.01%	184
2022 Q1	$714K	Buy	28,500 +4,500	+19%	+$126K	0.01%	196
2021 Q4	$874K	Buy	+24,000	New	+$842K	0.01%	199
2021 Q2	–	Sell	-1,547,710	Closed	-$79.3M	–	248
2021 Q1	$79.3M	Buy	1,547,710 +1,014,625	+190%	+$61M	0.68%	44
2020 Q4	$33M	Buy	+533,085	New	+$30.5M	0.27%	147

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

TimesSquare Capital Management's CCXI Position: Q3 2022 in Review

TimesSquare Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 41,700 shares — an estimated $1.03M sold.

TimesSquare Capital Management first reported a position in CCXI in Q4 2020 and held it in 5 quarters. The position peaked at $79.3M in Q1 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

TimesSquare Capital Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
TimesSquare Capital Management sold 41,700 ChemoCentryx, Inc. shares in Q3 2022, an estimated $1.03M.
TimesSquare Capital Management first reported a position in ChemoCentryx, Inc. in Q4 2020 and held it in 5 quarters.
TimesSquare Capital Management's ChemoCentryx, Inc. position peaked at $79.3M in Q1 2021.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on TimesSquare Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.